Concepedia

Richard Pollak

RP

Statistics

Publications

28

Citations

3K

H-Index

20

Active since

1985

Affiliations

Clinical Trials of Texas(Current)

The University of Texas Health Science Center at San Antonio

University of Alabama at Birmingham

Lotus Clinical Research

Chesapeake Research Group

Richard Pollak is an author at Clinical Trials of Texas specializing in medicine, health sciences, and pharmacology.

Top concepts

Publications per year

1985–2023

28

Publications

28

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

Carlos A. DiazGranados, Andrew J. Dunning, Murray Kimmel et al. · New England Journal of Medicine · 2014 · 820 citations · Full text

The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers

William A. Marston, Jason R. Hanft, Paul Norwood et al. · Diabetes Care · 2003 · 683 citations · Full text

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies

Boni E. Elewski, Phoebe Rich, Richard Pollak et al. · Journal of the American Academy of Dermatology · 2012 · 223 citations

, , +6

Selective Inhibition of Na <sub>V</sub> 1.8 with VX-548 for Acute Pain

J. W. Jones, Darin Correll, Sandra Lechner et al. · New England Journal of Medicine · 2023 · 221 citations

Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies

Boni E. Elewski, Raza Aly, Sheryl L. Baldwin et al. · Journal of the American Academy of Dermatology · 2015 · 158 citations · Full text

Rows per page

1–5 of 28